News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SCHIMMEL PAUL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 05/11/2023 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 200,000 shares
@ $2.25, valued at
$450k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Sold 8,447 shares
@ $3.639, valued at
$30.7k
|
|
| 05/08/2020 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 1,428 options to buy
@ $3.65, valued at
$5.2k
|
|
| 02/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2019 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 7,500 options to buy
@ $0.6391, valued at
$4.8k
|
|
| 07/02/2019 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $72.01, valued at
$648.1k
|
|
| 05/31/2019 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 20,000 options to buy
@ $4.22, valued at
$84.4k
|
|
| 05/10/2019 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $0.5834, valued at
$11.7k
|
|
| 04/16/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2018 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 147,225 shares
@ $0.542, valued at
$79.8k
|
|
| 09/10/2018 |
SC 13D
| SCHIMMEL PAUL reports a 5.3% stake in ATYR PHARMA, INC. |
| 09/05/2018 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 22,000 shares
@ $0.716, valued at
$15.8k
Bought 20,749 shares
@ $0.7571, valued at
$15.7k
|
|
| 08/31/2018 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 75,136 shares
@ $0.7199, valued at
$54.1k
Bought 89,275 shares
@ $0.7559, valued at
$67.5k
|
|
| 06/25/2018 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 20,000 options to buy
@ $8.98, valued at
$179.6k
|
|
| 06/22/2018 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $105.26, valued at
$947.3k
|
|
| 05/21/2018 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 150,000 shares
@ $0.9963, valued at
$149.4k
|
|
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2018 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 27,823 shares
@ $150, valued at
$4.2M
Exercised 15,000 options to buy
@ $59.25, valued at
$888.8k
Exercised 2,823 options to buy
@ $63.86, valued at
$180.3k
Exercised 10,000 options to buy
@ $30.09, valued at
$300.9k
|
|
| 09/05/2017 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 94,336 shares
@ $2.65, valued at
$250k
Bought 35,376 options to buy
@ $4.64, valued at
$164.1k
|
|
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2017 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $3.15, valued at
$63k
|
|
| 04/21/2017 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on Tocagen Inc |
| 04/12/2017 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on Tocagen Inc |
| 04/12/2017 |
3
| SCHIMMEL PAUL (Director) has filed a Form 3 on Tocagen Inc |
| 12/22/2016 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC |
| 12/19/2016 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC |
|
|
|